ES526765A0 - Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina - Google Patents

Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina

Info

Publication number
ES526765A0
ES526765A0 ES526765A ES526765A ES526765A0 ES 526765 A0 ES526765 A0 ES 526765A0 ES 526765 A ES526765 A ES 526765A ES 526765 A ES526765 A ES 526765A ES 526765 A0 ES526765 A0 ES 526765A0
Authority
ES
Spain
Prior art keywords
group
bencilamino
acilamino
amino
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES526765A
Other languages
English (en)
Spanish (es)
Other versions
ES8406440A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa GmbH filed Critical Degussa GmbH
Publication of ES8406440A1 publication Critical patent/ES8406440A1/es
Publication of ES526765A0 publication Critical patent/ES526765A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES526765A 1982-10-27 1983-10-26 Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina Granted ES526765A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3239790 1982-10-27

Publications (2)

Publication Number Publication Date
ES8406440A1 ES8406440A1 (es) 1984-07-01
ES526765A0 true ES526765A0 (es) 1984-07-01

Family

ID=6176726

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526765A Granted ES526765A0 (es) 1982-10-27 1983-10-26 Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina

Country Status (8)

Country Link
US (1) US4554281A (enExample)
EP (1) EP0110091B1 (enExample)
JP (2) JPS5995270A (enExample)
AT (1) ATE25078T1 (enExample)
AU (1) AU561450B2 (enExample)
DE (1) DE3369315D1 (enExample)
ES (1) ES526765A0 (enExample)
IT (2) IT1171880B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3665538D1 (en) * 1985-01-23 1989-10-19 Asta Pharma Ag Synergistic combination of flupirtin and non-steroidal anti-phlogistics
NO860825L (no) * 1985-03-23 1986-09-24 Degussa Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin.
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE19835918A1 (de) * 1998-08-07 2000-02-10 Dresden Arzneimittel Neue antikonvulsiv wirkende 4-Amino-1-aryl-pyridin-2-one und Verfahren zu deren Herstellung
US7799832B2 (en) * 2003-10-23 2010-09-21 Valeant Pharmaceuticals North America Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
EP1831170A4 (en) * 2004-12-14 2009-10-14 Astrazeneca Ab SUBSTITUTED AMINOPYRIDINES AND THEIR USE
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
NZ575652A (en) * 2006-08-23 2011-08-26 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
KR20090083479A (ko) * 2006-11-28 2009-08-03 밸리언트 파마슈티컬즈 인터내셔널 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
JP2009037141A (ja) 2007-08-03 2009-02-19 Ricoh Co Ltd 画像形成装置の管理装置及び管理システム
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
EP2231608A1 (en) * 2007-12-11 2010-09-29 NeuroSearch A/S Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
WO2009074594A1 (en) * 2007-12-11 2009-06-18 Neurosearch A/S Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
EP2231610A1 (en) * 2007-12-11 2010-09-29 NeuroSearch A/S Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
JP2011506390A (ja) * 2007-12-11 2011-03-03 ノイロサーチ アクティーゼルスカブ カリウムチャネル活性化因子として有用な、新規の２−ピロリジニル−３−アミド−６−アミノ−ピリジン誘導体
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
WO2019014547A1 (en) * 2017-07-14 2019-01-17 Texas Tech University System FUNCTIONALIZED PYRIDINE CARBAMATES HAVING ENHANCED NEUROPROTECTOR ACTIVITY
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
CA3155812A1 (en) 2019-11-08 2021-05-14 Cynthia Louise HARDEN Methods of treating depressive disorders
TW202245744A (zh) 2021-02-09 2022-12-01 加拿大商再諾製藥公司 治療失樂症之方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670523A1 (de) * 1966-05-12 1970-12-03 Degussa Verfahren zur Herstellung neuer substituierter Aminopyridine
BE764362R (en) * 1966-05-12 1971-09-16 Degussa Subst amino pyridienes production
JPS5541411B2 (enExample) * 1973-04-28 1980-10-24

Also Published As

Publication number Publication date
IT1171880B (it) 1987-06-10
IT8349222A1 (it) 1985-04-26
EP0110091B1 (de) 1987-01-21
ES8406440A1 (es) 1984-07-01
JPH0144170B2 (enExample) 1989-09-26
JPS5995269A (ja) 1984-06-01
US4554281A (en) 1985-11-19
AU2058283A (en) 1984-05-03
IT1171879B (it) 1987-06-10
ATE25078T1 (de) 1987-02-15
IT8349223A0 (it) 1983-10-26
EP0110091A1 (de) 1984-06-13
IT8349223A1 (it) 1985-04-26
DE3369315D1 (en) 1987-02-26
AU561450B2 (en) 1987-05-07
JPS5995270A (ja) 1984-06-01
IT8349222A0 (it) 1983-10-26

Similar Documents

Publication Publication Date Title
AU561450B2 (en) 2-amino-3-acylamino-6-benzylamino pyridine derivatives
ES526318A0 (es) Procedimiento para la obtencion de derivados de 1-hidroxietil-triazolilo sustituidos
ES493275A0 (es) Procedimiento para la preparacion de nuevas 2-alcoxi-fenil- imidazo(4,5-b)piridinas
ES519650A0 (es) Un procedimiento para obtener derivados de indanilbenzamida.
SE8502525D0 (sv) 1,3-oxazolidine-2-one derivatives and processes for their preparation
ES515872A0 (es) "procedimiento para la preparacion de nuevos derivados de acidos 4-fenoxialcarboxilicos sustituidos con radicales haterociclicos".
ES497693A0 (es) Procedimiento para la obtencion de derivados de benzotiazol
ES520774A0 (es) Procedimiento para la preparacion de derivados de tiometilpiridina.
ES497105A0 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli nas-(2)sustituidas.
DK373985A (da) Substituerede pyridazinoner samt deres fremstilling og anvendelse
AU564739B2 (en) Acridanone derivatives
ES515201A0 (es) "procedimiento para la fabricacion de derivados n- susbtituidos de la tetrahidroisftalimida".
DK601883D0 (da) Phenyl-propanolderivater
ES532180A0 (es) Procedimiento para preparar nuevas semicarbazidas
ES483138A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
SE8105297L (sv) Imidazolderivat